CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 8, 2006--EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a developer of innovative pharmaceuticals for magnetic resonance imaging (MRI), today announced that it will release fourth quarter and year end 2005 financial results on Thursday, February 16, 2006, before the open of regular market trading hours. A conference call to discuss these results and provide an update on clinical, regulatory and business development activities is scheduled for later that day, Thursday, February 16, 2006, at 10:00 a.m. Eastern Time.
